Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients
Chisako Iriyama(Fujita Health University), Akihiro Tomita(Nagoya University), Harutaka Katano(National Institute of Infectious Diseases), Tetsuya Tsukamoto(Memorial Sloan Kettering Cancer Center), Takaya Ichikawa(Sapporo University), Akito Kawai(Fujita Health University), Shun Iida(National Institute of Infectious Diseases), Yoshitaka Oda(Hokkaido University), Tadaki Suzuki(National Institute of Infectious Diseases), Masahiro Suzuki(Fujita Health University), Takasuke Fukuhara(Hokkaido University), Tomokazu Tamura(Hokkaido University), Naganori Nao(Sapporo University), Shinya Tanaka(Hokkaido University), Mitsunaga Iwata(Fujita Health University), Yasushi Ishii(Sapporo City General Hospital), Takayuki Murata(Fujita Health University), Takashi Ishio(Sapporo Kosei General Hospital), Takahiro Tsuji(Sapporo City General Hospital), Makoto Ibata(Hokkaido University), Akifumi Kamiyama(Hokkaido University), R. Kawai(Fujita Health University), Mutsumi Takahata(Sapporo Kosei General Hospital), Shimpei Nakagawa(Sapporo City General Hospital), Hirokazu Adachi(Aichi Prefectural Government), Nanase Okazaki(Sapporo City General Hospital), Hikoyu Suzuki, Yohei Doi(Fujita Health University)
Cited by 10
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
A unified nomenclature for peroxisome biogenesis factors.
|The Journal of Cell Biology|1996|418
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328